ESMO Preceptorship on Gastroesophageal Cancer 2025: Lima

- Start date
- 09 Apr 2025
- End date
- 10 Apr 2025
- Location
- Lima, Peru
Learning objectives
- Understand best clinical practices in the multidisciplinary management of gastroesophageal cancer, both in the neoadjuvant and metastatic settings
- Comprehend the importance of pathology and histo-prognostic factors in the treatment of gastroesophageal cancers
- Learn how to manage patients after disease progression, addressing side effects of treatments and special situations
- Gain insights into the evolving field of biomarker-targeted therapy and immunotherapy for gastroesophageal cancer
Travel grant
In addition to the course registration and the hotel accommodation, a travel grant of maximum 800 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that immigration visa costs are NOT covered by the travel grant and are the participant's responsibility.
Accreditation
The programme of this event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.